7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
8.51%
TRI TECH HOL TRIT
5.88%
SONIC FOUNDR SOFO
4.86%
FLOWERS FOOD FLO
4.07%
OILTANKING P OILT
2.60%

Progressive Corp. (PGR)

by Zacks Equity Research

June 01, 2012 | Comments : 0 Recommended this article: (0)
PGR

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We are downgrading Progressive Corp. (PGR) to Underperform from Neutral as the company continues to deliver lower net investment income and incur higher expenses. Progressive's first quarter earnings surpassed the Zacks Consensus Estimate by $0.03 but fell below the year-ago quarter.

Lower net investment gains and higher expenses resulted in lower numbers during the quarter. Considering the state of the economy, we expect significant pressure on underwriting margins and restriction in its top-line growth in the near term.

Our six-month target price of $20.00 equates to 13.8x our earnings estimate for 2012. Combined with $0.41 per share annual dividend this price target implies an expected negative total return of 7.3% over that period. This is consistent with our Underperform recommendation on the shares.

Read the full reports :

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.